Y. Chou

发表

Resistance to apoptosis induced by alkylating agents in v‐Ha‐ras‐transformed cells due to defect in p53 function

M. Kuo, Y. Chou, Y. Chau, 1997, Molecular carcinogenesis.

Quantification of ovarian cancer markers with integrated microfluidic concentration gradient and imaging nanohole surface plasmon resonance.

D. Sinton, R. Gordon, Y. Chou, 2013, The Analyst.

Pharmacophore-based virtual screening and biological evaluation of small molecule inhibitors for protein arginine methylation.

Hualiang Jiang, Y. Chou, Chao Yang, 2012, Journal of medicinal chemistry.

Androgens Upregulate Cdc25C Protein by Inhibiting Its Proteasomal and Lysosomal Degradation Pathways

Y. Chou, Sakthivel Muniyan, Ming-Fong Lin, 2013, PloS one.

Simultaneous determination of cefepime and L-arginine by micellar electrokinetic chromatography and applications to commercial injections.

Y. Chou, Hsin-Lung Wu, Su‐Hwei Chen, 2005, Journal of separation science.

Cellular prostatic acid phosphatase (cPAcP) serves as a useful biomarker of histone deacetylase (HDAC) inhibitors in prostate cancer cell growth suppression

C. Chen, Y. Chou, Sakthivel Muniyan, 2015, Cell & Bioscience.

Discovery, synthetic methodology, and biological evaluation for antiphotoaging activity of bicyclic[1,2,3]triazoles: in vitro and in vivo studies.

Y. Chou, K. Kuo, Jeh-Jeng Wang, 2013, Journal of medicinal chemistry.

Differential induction of apoptosis in oncogene-transformed NIH 3T3 cells by methylmethanesulfonate.

M. Kuo, Y. Chou, Y. Chau, 1996, Biochemical pharmacology.

Human Prostatic Acid Phosphatase in Prostate Carcinogenesis

Y. Chou, Sakthivel Muniyan, Ming-Fong Lin, 2013 .

Dynamics of antioxidant heme Oxygenase-1 and pro-oxidant p66Shc in promoting advanced prostate cancer progression.

Y. Chou, R. Oberley-Deegan, E. Kosmacek, 2022, Free radical biology & medicine.

Trace analysis of zotepine and its active metabolite in plasma by capillary electrophoresis with solid phase extraction and head-column field-amplified sample stacking.

Y. Chou, Su‐Hwei Chen, S. Lin, 2005, Journal of chromatography. A.

Synthesis of a phosphinated tetracyanate ester and its miscible blend with 4,4′-oxydianiline/phenol-based benzoxazine

Y. Chou, T. Juang, C. Lin, 2015 .

Antiproliferative activity of novel imidazopyridine derivatives on castration-resistant human prostate cancer cells.

Y. Chou, Shafiq A. Khan, V. Odero-Marah, 2014, Cancer letters.

Analysis of kanamycin A in human plasma and in oral dosage form by derivatization with 1-naphthyl isothiocyanate and high-performance liquid chromatography.

Y. Chou, Su‐Hwei Chen, Yi Liang, 2006, Journal of separation science.

p66Shc longevity protein regulates the proliferation of human ovarian cancer cells

Y. Chou, S. Lele, Shafiq A. Khan, 2015, Molecular carcinogenesis.

Histone deacetylase inhibitor valproic acid suppresses the growth and increases the androgen responsiveness of prostate cancer cells.

Y. Chou, Ming-Fong Lin, Nagendra K. Chaturvedi, 2011, Cancer letters.

Design and synthesis of pyrrolobenzodiazepine-gallic hybrid agents as p53-dependent and -independent apoptogenic signaling in melanoma cells.

Ying-Ting Lin, Y. Chou, K. Kuo, 2016, European journal of medicinal chemistry.

Heteronemin Is a Novel c‐Met/STAT3 Inhibitor Against Advanced Prostate Cancer Cells

Y. Chou, Wen-Jeng Wu, Deng-Chyang Wu, 2016, The Prostate.

Validation of the effects of TGF-β1 on tumor recurrence and prognosis through tumor retrieval and cell mechanical properties

M. Yeh, M. Tang, Y. Chou, 2014, Cancer Cell International.

Reactive oxygen species (ROS) by p66Shc longevity protein mediate non-genomic androgen action via tyrosine phosphorylation signaling to enhance tumorigenicity of prostate cancer cells

Y. Chou, S. Lele, Yan Xie, 2013 .

Reactive oxygen species induced by p66Shc longevity protein mediate nongenomic androgen action via tyrosine phosphorylation signaling to enhance tumorigenicity of prostate cancer cells.

Y. Chou, S. Lele, Yan Xie, 2012, Free radical biology & medicine.

p66Shc regulates migration of castration-resistant prostate cancer cells.

S. Batra, Y. Chou, R. Oberley-Deegan, 2018, Cellular signalling.

Quantification of meropenem in plasma and cerebrospinal fluid by micellar electrokinetic capillary chromatography and application in bacterial meningitis patients.

Y. Chou, Yuan-Han Yang, Su‐Hwei Chen, 2007, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

Factor VII-Induced MicroRNA-135a Inhibits Autophagy and Is Associated with Poor Prognosis in Hepatocellular Carcinoma

Y. Chou, Yu-Fan Cheng, Chao-Pin Kung, 2017, Molecular therapy. Nucleic acids.

Ran GTPase-Activating Protein 1 Is a Therapeutic Target in Diffuse Large B-Cell Lymphoma

Wei‐Chao Chang, Chung-Hsuan Chen, Y. Chou, 2013, PloS one.

Anti-Androgen Abiraterone Acetate Improves the Therapeutic Efficacy of Statins on Castration-Resistant Prostate Cancer Cells.

Y. Chou, Y. Tu, Ming-Fong Lin, 2017, Journal of oncology research and therapy.

Non‐mitotic effect of albendazole triggers apoptosis of human leukemia cells via SIRT3/ROS/p38 MAPK/TTP axis‐mediated TNF‐&agr; upregulation

Y. Chou, Ying-Jung Chen, Long-Sen Chang, 2019, Biochemical pharmacology.

Distinct p53-mediated G1/S checkpoint responses in two NIH3T3 subclone cells following treatment with DNA-damaging agents.

M. Kuo, Y. Chou, J. Shew, 1996, Oncogene.

Antiproliferative activity of novel imidazopyridine derivatives on castration-resistant human prostate cancer cells.

Y. Chou, Shafiq A. Khan, V. Odero-Marah, 2014, Cancer Letters.

Determination of ceftazidime in plasma and cerebrospinal fluid by micellar electrokinetic chromatography with direct sample injection

Y. Chou, Yuan-Han Yang, Su‐Hwei Chen, 2004, Electrophoresis.

Enantioseparation of cetirizine by sulfated-beta-cyclodextrin-mediated capillary electrophoresis.

Y. Chou, Su‐Hwei Chen, Wei-Shan Huang, 2008, Journal of separation science.